Company insight
High-CBD raw material brings opportunities
A new high-CBD raw material is available to the nutraceuticals industry. With Bedrocan as an experienced cannabis cultivator, its CEO, Jaap Erkelens, explains why non-hemp CBD of consistent content is an advantage.
edrocan, a Dutch cultivator known for its pharmaceutical-grade medicinal cannabis, has recently launched a high-CBD raw material that brings opportunities for a cost-effective and quality production of CBD-based nutraceuticals. The product, branded as Bedrolina, contains up to 14% CBD and less than 1% THC and is available in ‘cut flos’ (milled) form and in whole dried flower form.
B
Jaap Erkelens, CEO,
Bedrocan CBD products have become
increasingly popular in the nutraceuticals industry, and the market is expanding as more jurisdictions regulate CBD across the globe. However, the options for reliable raw materials with consistent contents and high CBD levels seem limited. So, how can manufacturers source quality raw materials to improve their CBD products?
Many manufacturers of CBD-based products mostly rely on hemp-derived raw materials as it is the most available option
in many jurisdictions. However, these raw materials usually contain a mix of plant materials cultivated in different manners and with varied levels of active ingredients to achieve a certain CBD percentage. Bedrocan’s CEO, Jaap Erkelens, argues that hemp varieties are not the best choice for manufacturing CBD products, saying: “Hemp varieties often contain a lower CBD percentage, which means that more biomass is needed. In addition, these hemp varieties are not suitable for medicinal applications.”
Experience matters As the world’s most experienced cultivator of cannabis with consistent levels of active
ingredients, Bedrocan has launched this new high-CBD variety to offer a reliable and quality-controlled cannabis raw material for the nutraceuticals industry. The company’s unique cultivation methods ensure a non-hemp CBD with standardised levels of active ingredients, batch-to-batch. This allows manufacturers to use less plant material in the manufacturing of CBD products in comparison with hemp-derived raw materials. Additionally, Bedrocan has a history of consistent supply availability, an important advantage in a market with growing demand. Bedrocan’s expertise, which is rooted in the agricultural traditions of the northern Netherlands, has been built on the cultivation of a variety of plants under standardised and controlled conditions. The company is constantly looking to improve its cultivation expertise through an active R&D programme that conducts research into plant genetics to enhance the level of active ingredients, including rare cannabinoids (such as CBG and CBN). Besides growing cannabis indoors in the Netherlands, and recently in Denmark, the company has also started an outdoor cultivation project, growing high-CBD and other novel medicinal plants through a partnership in Suriname. Contract manufacturing services are also among the company’s scope of activities. ●
Bedrocan will be present with a booth (#4A122) at Vitafoods Europe 2025 to present its portfolio specifically targeted at the nutraceuticals industry.
Bedrocan’s high-CBD cannabis offers a reliable raw material for the nutraceuticals industry. Ingredients Insight /
www.ingredients-insight.com
https://bedrocan.com 57
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58 |
Page 59 |
Page 60 |
Page 61 |
Page 62 |
Page 63 |
Page 64 |
Page 65 |
Page 66 |
Page 67 |
Page 68 |
Page 69 |
Page 70 |
Page 71 |
Page 72 |
Page 73 |
Page 74 |
Page 75 |
Page 76 |
Page 77 |
Page 78 |
Page 79 |
Page 80 |
Page 81 |
Page 82 |
Page 83 |
Page 84 |
Page 85 |
Page 86 |
Page 87 |
Page 88 |
Page 89 |
Page 90 |
Page 91 |
Page 92 |
Page 93 |
Page 94
